Stonepine Capital Management’s CalciMedica CALC Stock Holding History

Stonepine Capital Management’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-85,000	Closed	-$136K	–	62
2025 Q2	$136K	Sell	85,000 -282,371	-77%	-$485K	0.13%	55
2025 Q1	$615K	Sell	367,371 -101,422	-22%	-$253K	0.6%	33
2024 Q4	$1.66M	Buy	+468,793	New	+$1.64M	1.34%	22
2024 Q2	–	Sell	-522,602	Closed	-$2.17M	–	26
2024 Q1	$2.17M	Buy	+522,602	New	+$2.39M	1.72%	11

Other funds holding CALC

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MPM

Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

SFFS

Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return

SSIM

Sheets Smith Investment Management Houston, Texas $154M AUM 66.97% 1-Year Est. Return

Stonepine Capital Management's CALC Position: Q3 2025 in Review

Stonepine Capital Management sold out of CalciMedica (CALC) in Q3 2025, closing a stake of 85,000 shares — an estimated $136K sold.

Stonepine Capital Management first reported a position in CALC in Q1 2024 and held it in 4 quarters. The position peaked at $2.17M in Q1 2024. 31 funds tracked by Wall St. Rank hold CALC as of Q3 2025.

Stonepine Capital Management reported no remaining CalciMedica position as of Q3 2025 after selling out during the quarter.
Stonepine Capital Management sold 85,000 CalciMedica shares in Q3 2025, an estimated $136K.
Stonepine Capital Management first reported a position in CalciMedica in Q1 2024 and held it in 4 quarters.
Stonepine Capital Management's CalciMedica position peaked at $2.17M in Q1 2024.
31 funds tracked by Wall St. Rank held CalciMedica as of Q3 2025.

Based on Stonepine Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.